Professor Dame Janet Husband has decided to step down from the board of Spire Healthcare Group at its annual general meeting on 14 May 2025 and will not seek re-election by shareholders.
Spire also announced the following non-executive director appointments effective as of today (6 March).
Non-executive director appointments
Sir David Sloman (pictured right) will join as a non-independent non-executive director.
Sloman will become a member of the company’s clinical governance and safety committee on appointment and will replace Husband as chairman on 14 May 2025. He will also take on the role of vice chairman from that date.
Sloman has had a long career in healthcare management, predominantly in the NHS. He has held several CEO roles at several NHS trusts, including the Royal Free London NHS Foundation Trust, the Whittington Hospital NHS Trust and NHS Haringey Trust.
During December 2021 and August 2023, he was the COO of NHS England, where he was responsible for overseeing all NHS operational delivery, including the response to the Covid-19 pandemic.
Sloman is a non-executive director of Axa UK and Ireland, a board member of Health Data Research UK, a fellow of the Royal Society of Medicine, a senior fellow of the Institute for Healthcare Improvement and a trustee of the Royal College of Radiologists.
As a result of his appointment with Axa UK and Ireland, Spire said it does not consider Sloman to be an independent director.
Jill Anderson (pictured left) will join as an independent non-executive director and become a member of the company’s audit and risk committee on appointment and will become committee chairwoman from 14 May 2025.
She will also become a member of the remuneration committee on appointment.
Anderson has 30 years of experience in the healthcare sector, including executive responsibility in finance, commercial, research and supply chain functions across large multinational organisations principally with GSK.
She is a trustee of Amref UK, an NGO focused on healthcare in Africa, and was an associate non-executive director of London Ambulance Service until 2022.
Sir Ian Cheshire, non-executive chairman at Spire Healthcare, said: “We are delighted that both Jill and Sir David have agreed to join Spire’s board.
“The breadth of their expertise and experience in healthcare will be a highly valuable addition to our board and the company.
“I look forward to welcoming Sir David as the new chairman of the clinical governance and safety committee and Jill as the new chair of the audit and risk committee.
“I would also like to thank Dame Janet for her considerable contribution to Spire since the company listed in 2014 and also Debbie White for chairing the audit and risk committee on an interim basis.”
